Evaluation of frequent milkout for treatment of cows with experimentally induced Escherichia coil mastitis.

OBJECTIVE To evaluate the effect of frequent milkout (FMO) on the outcome of experimentally induced Escherichia coli mastitis in cows. DESIGN Randomized complete block study. ANIMALS 16 Holstein dairy cows. PROCEDURE Cows were randomly assigned to 1 of 4 groups and were either not infected and not treated (NI-NT), experimentally infected with E coli and not treated (EC-NT), not infected and FMO (NI-FMO), or experimentally infected with E coli and FMO (EC-FMO). The infected quarter in cows in FMO groups was milked out every 4 hours from 16 to 36 hours and every 6 hours from 36 to 84 hours after challenge, with the aid of oxytocin administration. Somatic cell counts (SCC); times to bacterial, clinical, and systemic cures; and serum concentrations of a-lactalbumin were determined. RESULTS Use of FMO did not appear to affect SCC. For EC-NT and EC-FMO groups, mean bacterial cure times were 203 and 159 hours, clinical cure times were 276 and 360 hours, and systemic cure times were 144 and 159 hours, respectively; these times were not significantly different. Concentrations of a-lactalbumin were significantly increased in the EC-NT group at 12 hours and in the NI-FMO group at 36 and 60 hours after challenge, compared with values of cows in other treatment groups. CONCLUSIONS AND CLINICAL RELEVANCE Compared with results in control cows, FMO does not appear to be an efficacious treatment for experimentally induced moderate to severe E coli mastitis.

[1]  Mayo Ka,et al.  Chyloperitoneum and abdominal adhesions in a miniature horse. , 1999 .

[2]  J. Hogan,et al.  Therapy of experimentally induced coliform mastitis with a Propionibacterium acnes product. , 1994, Journal of dairy science.

[3]  R. Erskine,et al.  Advances in the therapy for mastitis. , 1993, The Veterinary clinics of North America. Food animal practice.

[4]  Alison L. Van Eenennaam,et al.  Efficacy of intramammary antibiotic therapy for treatment of clinical mastitis caused by environmental pathogens. , 1993, Journal of dairy science.

[5]  D. E. Pritchard,et al.  Costs associated with selected preventive practices and with episodes of clinical mastitis in nine herds with low somatic cell counts. , 1991, Journal of the American Veterinary Medical Association.

[6]  G. E. Ward,et al.  Evaluation of systemic administration of gentamicin for treatment of coliform mastitis in cows. , 1990, Journal of the American Veterinary Medical Association.

[7]  J. Cullor,et al.  Clinical mastitis in two California dairy herds participating in contagious mastitis control programs. , 1990, Journal of dairy science.

[8]  D. E. Pritchard,et al.  Field survey of clinical mastitis in low somatic cell count herds. , 1989, Journal of dairy science.

[9]  R. P. Natzke,et al.  Characterization of clinical mastitis records from one herd in a subtropical environment. , 1988, Journal of dairy science.

[10]  M. A. Campbell,et al.  Incidence and types of clinical mastitis in dairy herds with high and low somatic cell counts. , 1988, Journal of the American Veterinary Medical Association.

[11]  T. Mcfadden,et al.  Alpha-lactalbumin in bovine serum: relationships with udder development and function. , 1987, Journal of dairy science.

[12]  K. Ebner,et al.  Resolution of a soluble lactose synthetase into two protein components and solubilization of microsomal lactose synthetase. , 1966, The Journal of biological chemistry.